Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1996
12/03/1996US5580570 Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
12/03/1996US5580562 Preparations and uses thereof for immunosuppression
12/03/1996US5580556 Pharmaceutical compositions containing interferons and fatty acids
12/03/1996US5580553 Hair and skin cleansers; good feel, nontoxic
12/03/1996US5580552 7-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
12/03/1996US5580549 Bleaching; 2-hydroxybenzoic acid compound
12/03/1996US5580543 Texaphyrins as radiation sensitizers
12/03/1996CA2176766A1 Indanylpiperidines as melatonergic agents
12/03/1996CA2175395A1 Melatonergic indanyl piperazines or homopiperazines
12/03/1996CA2028140C Novel bacteriocin compositions for use as enhanced broad range
12/03/1996CA2016575C Method of aiding cessation of smoking
12/03/1996CA1338764C Polyamine derivatives
12/01/1996CA2177644A1 Polymeric prodrugs for beta-lactamase and uses thereof
12/01/1996CA2177538A1 Apparatus, method and composition for preserving media in tip of solution dispenser
12/01/1996CA2150710A1 Alleviation of cardiotoxic effects of anthracycline glycosides
11/1996
11/28/1996WO1996037775A1 Methods for g protein coupled receptor activity screening
11/28/1996WO1996037626A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
11/28/1996WO1996037623A1 Retroviral vectors
11/28/1996WO1996037500A1 Novel quinoxaline dione derivatives, their production and their use in medicaments
11/28/1996WO1996037499A1 Novel cephem derivatives
11/28/1996WO1996037498A1 5H-THIAZOLO[3,2-a]PYRIMIDIN-5-ONE DERIVATIVES
11/28/1996WO1996037497A1 Low molecular weight bicyclic-urea type thrombin inhibitors
11/28/1996WO1996037496A1 Substituted camptothecin derivatives and process for their preparation
11/28/1996WO1996037492A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
11/28/1996WO1996037490A1 Benzopyrans and pharmaceutical compositions containing them
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037488A1 Piperazine derivatives
11/28/1996WO1996037487A1 Process for producing thiazolidine derivatives
11/28/1996WO1996037486A1 (2-morpholinylmethyl)benzamide derivatives
11/28/1996WO1996037485A1 2-amino-benzoxazinones for the treatment of viral infections
11/28/1996WO1996037482A1 Improved isoxazoline fibrinogen receptor antagonists
11/28/1996WO1996037475A1 Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form
11/28/1996WO1996037462A1 Amide derivatives and external skin or hair care preparations
11/28/1996WO1996037456A1 New catechol derivatives
11/28/1996WO1996037230A1 Immunostimulating-wound healing compositions and methods for preparing and using same
11/28/1996WO1996037229A1 Antihistamine-wound healing compositions and methods for preparing and using same
11/28/1996WO1996037228A1 Antibacterial-wound healing compositions and methods for preparing and using same
11/28/1996WO1996037227A1 Dermatological-wound healing compositions and methods for preparing and using same
11/28/1996WO1996037226A2 Combinations for the treatment of parkinsonism containing selective nmda antagonists
11/28/1996WO1996037224A1 Methods of treating colon cancer utilizing tumor-specific antibodies
11/28/1996WO1996037223A1 Muscle trophic factor
11/28/1996WO1996037218A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996WO1996037214A2 Compositions of interleukin and pyrimidine nucleosides
11/28/1996WO1996037210A2 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
11/28/1996WO1996037209A1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast
11/28/1996WO1996037208A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/28/1996WO1996037205A1 Remedy for endotoxinemia and multiple organ failure induced thereby
11/28/1996WO1996037204A1 Inhibitors of farnesyl-protein transferase
11/28/1996WO1996037203A1 Method to increase retinal blood flow
11/28/1996WO1996037202A1 Dosage form comprising oxybutynin
11/28/1996WO1996037201A2 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY
11/28/1996WO1996037200A1 Use of dha as a pharmaceutical composition
11/28/1996WO1996037199A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
11/28/1996WO1996037198A1 Use by inhalation of antidepressants for the treatment of asthma
11/28/1996WO1996037197A1 Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase
11/28/1996WO1996037196A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996WO1996037194A1 Delivery vehicles comprising stable lipid/nucleic acid complexes
11/28/1996WO1996037193A1 Topically applicable agents for treating and preventing alopecia
11/28/1996WO1996037191A1 Antibacterial compositions
11/28/1996WO1996037190A1 Stable, concentrated, locally-tolerated erythromycylamine solutions
11/28/1996WO1996037188A1 Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament
11/28/1996WO1996037187A1 Cosmetic or dermatological preparations containing phytic acid
11/28/1996WO1996032931A3 Composite with sodium starch glycolate as a support material and products thereof
11/28/1996WO1996030010A3 Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections
11/28/1996WO1996029867A3 Fast acting and persistent topical antiseptic
11/28/1996WO1996029065A3 Aminotetralin derivative for the therapy of cardiovascular diseases
11/28/1996WO1996025931A3 Use of fused benzothiazoles as neuroprotectants
11/28/1996WO1996024581A3 Derivatives of pyridil piperazine or pyridazinyl piperazyl, process for production thereof and medicaments containing these compounds
11/28/1996DE19519979A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments
11/28/1996DE19519273A1 Topisch applizierbare Mittel zur Behandlung und Prophylaxe der Alopezie Topically applicable agent for the treatment and prophylaxis of alopecia
11/28/1996DE19518917A1 Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen Stable, concentrated locally acceptable solutions erythromycylamine
11/28/1996DE19518845A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure Cosmetic or dermatological preparations containing phytic acid
11/28/1996DE19517145C1 Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron Transdermal therapeutic system (TTS) for the administration of testosterone
11/28/1996CA2510391A1 Dosage form comprising oxybutynin
11/28/1996CA2222061A1 Agents that can be administered topically for treatment and prophylaxis of alopecia
11/28/1996CA2222050A1 Improved isoxazoline fibrinogen receptor antagonists
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2222034A1 2-amino-benzoxazinones for the treatment of viral infections
11/28/1996CA2222018A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996CA2221980A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
11/28/1996CA2221935A1 Method of treating colon cancer utilizing tumor-specific antibodies
11/28/1996CA2221818A1 Parasitic helminth venom allergen antigen 5-like genes and proteins
11/28/1996CA2221701A1 Inhibitors of farnesyl-protein transferase
11/28/1996CA2221695A1 New quinoxalinedione derivatives, their production and use in pharmaceutical agents
11/28/1996CA2221458A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
11/28/1996CA2221236A1 Methods and compositions for inhibiting 5.alpha.-reductase activity
11/28/1996CA2220971A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/28/1996CA2220950A1 Delivery vehicles comprising stable lipid/nucleic acid complexes
11/28/1996CA2220837A1 Compositions of interleukin and pyrimidine nucleosides
11/28/1996CA2219824A1 Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament
11/28/1996CA2218816A1 Low molecular weight bicyclic-urea type thrombin inhibitors
11/28/1996CA2218726A1 Methods for g protein coupled receptor activity screening
11/28/1996CA2218539A1 Immunostimulating-wound healing compositions and methods for preparing and using same
11/28/1996CA2195979A1 Use of dha as a pharmaceutical composition
11/28/1996CA2195578A1 5h-thiazolo[3,2-a]pyrimidin-5-one derivatives
11/28/1996CA2194700A1 Substituted camptothecin derivatives and process for their preparation
11/28/1996CA2191597A1 Antibacterial compositions
11/27/1996EP0744397A2 Fluorophenyl substituted alkenyl carboxylic acid guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agent as well as a medicament containing them
11/27/1996EP0744176A2 Methods for inhibiting bone loss
11/27/1996EP0744175A2 Cosmetic or dermatological compositions containing alpha-hydroxy fatty acids
1 ... 6855 6856 6857 6858 6859 6860 6861 6862 6863 6864 6865 6866 6867 6868 6869 6870 6871 6872 6873 6874 6875 ... 7860